Japan Approves 2 New Regenerative Medicine Products for Heart Failure & Parkinson’s Disease
Japan has given the green light to two innovative regenerative medicine products. ReHeart, developed by Cuorips Inc., will help patients with severe heart failure by promoting new blood vessels underneath their hearts. Amchepry, created by Sumitomo Pharma Co. and Racthera Inc., uses human iPS cells to treat Parkinson’s disease, improving motor function in patients. These … Read more